Hardin Capital Partners
LLY icon

Hardin Capital Partners’s Eli Lilly LLY Stock Holding History

Hardin Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.46M Buy
1,266
+160
+14% +$189K 0.72% 25
2026
Q2 		$1.34M Sell
1,106
-158
-13% -$161K 0.62% 27
2026
Q1 		$1.16M Sell
1,264
-1
-0.1% -$1.01K 0.54% 33
2025
Q4 		$1.36M Buy
1,265
+133
+12% +$127K 0.64% 23
2025
Q3 		$864K Buy
1,132
+28
+3% +$20.8K 0.46% 40
2025
Q2 		$857K Sell
1,104
-171
-13% -$133K 0.5% 36
2025
Q1 		$1.05M Buy
1,275
+5
+0.4% +$4.16K 0.65% 22
2024
Q4 		$980K Sell
1,270
-19
-1% -$15.7K 0.59% 26
2024
Q3 		$1.18M Buy
1,289
+3
+0.2% +$2.7K 0.67% 19
2024
Q2 		$1.16M Buy
+1,286
New +$1.03M 0.76% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Hardin Capital Partners's LLY Position: Q3 2026 in Review

Hardin Capital Partners increased its Eli Lilly (LLY) stake by 14% in Q3 2026, buying an estimated $189K and bringing the position to 1,266 shares worth $1.46M. The position accounts for 0.72% of the portfolio, ranked #25.

Hardin Capital Partners first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Hardin Capital Partners held 1,266 shares of Eli Lilly worth $1.46M as of Q3 2026.
  • Hardin Capital Partners bought 160 Eli Lilly shares in Q3 2026, an estimated $189K.
  • Eli Lilly made up 0.72% of Hardin Capital Partners's portfolio in Q3 2026, its #25 holding.
  • Hardin Capital Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Hardin Capital Partners's 13F filing for Q3 2026, filed 9 Oct 2026.